Crescita Therapeutics Inc. (TSE:CTX – Get Free Report)’s stock price dropped 3.4% during mid-day trading on Thursday . The stock traded as low as C$0.57 and last traded at C$0.57. Approximately 5,046 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 21,741 shares. The stock had previously closed at C$0.59.
Crescita Therapeutics Price Performance
The stock has a market cap of C$11.05 million, a PE ratio of -3.80 and a beta of 1.71. The company has a 50-day simple moving average of C$0.62 and a 200-day simple moving average of C$0.52. The company has a debt-to-equity ratio of 6.02, a current ratio of 3.37 and a quick ratio of 2.29.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Recommended Stories
- Five stocks we like better than Crescita Therapeutics
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- What Are Dividend Achievers? An Introduction
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- Profitably Trade Stocks at 52-Week Highs
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
